Metabolism, uptake, and transepithelial transport of the diastereomers of Val-Val in the human intestinal cell line, Caco-2

Pharmaceutical Research

Volumn 13, Issue 8, 1996, Pages 1213-1218

  Tamura, Kiyoshi ^a   Bhatnagar, Pradip K ^b   Takata, Joanne S ^b   Lee, Chao Pin ^b   Smith, Philip L ^b   Borchardt, Ronald T ^a  

^a UNIVERSITY OF KANSAS   (United States)

^b GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Caco 2; Carnosine; Cephalexin; Dipeptides; Oligopeptide transport; Structure transport

Indexed keywords

CARRIER PROTEIN; DIPEPTIDE; UNCLASSIFIED DRUG; VALYLVALINE;

ARTICLE; CELL CULTURE; CONTROLLED STUDY; DIASTEREOISOMER; HUMAN; HUMAN CELL; INTESTINE CELL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN METABOLISM; PROTEIN TRANSPORT;

BIOLOGICAL TRANSPORT; CACO-2 CELLS; CEPHALEXIN; DIPEPTIDES; EPITHELIUM; HUMANS; STEREOISOMERISM; TRITIUM;

EID: 0029776737     PISSN: 07248741     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1016068421243     Document Type: Article

References (25)

1. C. H. Gochoco, F. M. Ryan, J. Miller, P. L. Smith, and I. J. Hidalgo. Uptake and transepitherial transport of orally absorbed cephalosporine cephalexin in the human intestinal cell line, Caco-2. Int. J. Pharm. 104:187-202 (1994).
2. D. M. Matthews and S. A. Adibi. Peptide absorption. Gastroenterology 71:151-161 (1976).
3. V. Ganapathy and F. H. Leibach. Is intestinal peptide transport energized by a proton gradient? Am. J. Physiol. 249:G153-G160(1985).
4. A. H. Dantzig and L. Bergin. Carrier-mediated uptake of cephalexin in human intestinal cells. Biochem. Biophvs. Res. Commun. 155:1082-1087 (1988).
5. I. J. Hidalgo, F. M. Ryan, G. J. Marks, and P. L. Smith. pH-dependent transepithelial transport of cephalexin in rabbit intestinal mucosa. Int. J. Pharm. 98:83-92 (1993).
6. P. W. Swaan, M. C. Stehouwer, R. I. C. Blok, and J. J. Tukker. Prodrug approach using the intestinal peptide carrier. Pharm. Res. 10:S-295 (1993).
7. M. Hu, P. Subramanian, H. I. Mosberg, and G. L. Amidon. Use of the peptide carrier system to improve the intestinal absorption of L-α-methyldopa: carrier kinetics, intestinal permeabilities, and in vitro hydrolysis of dipeptidyl derivatives of L-α-methyldopa. Pharm. Res. 6:66-70 (1989).
8. J. P. F. Bai. pGlu-L-Dopa-Pro: Tripeptide prodrug targeting the intestinal peptide transporter for absorption and tissue enzymes for conversion. Pharm. Res. 12:1101-1104 (1995).
9. P. L. Smith, E. P. Eddy, C.-P. Lee, and G. Wilson. Exploitation of the intestinal oligopeptide transporter to enhance drug absorption. Drug Delivery 1:103-111 (1993).
10. W. Kramer, F. Girbig, U. Gutjahr, S. Kowalewski, F. Adam, and W. Schiebler. Intestinal absorption of β-lactam antibiotics and oligopeptides. Eur. J. Biochem. 204:923-930 (1992).
11. K. Miyazaki, K. Iseki, and T. Arita. Intestinal absorption of several β-lactam antibiotics. IV. Binding to the various components in the intestinal mucosa of rat and role in absorption process. J. Pharm. Dyn. 5:593-602 (1982).
12. F. M. Ryan and P. L. Smith. Effects of altering fluid transport on the absorption of benzylpenicillin and mannitol across rat intestinal mucosa in vitro. Pharm. Res. 6:S88 (1989).
13. J. Dyer, R. B. Beechey, J.-P. Gorvel, R. T. Smith, R. Wootton, and S. P. Shirazi-Beechey. Glycyl-L-proline transport in rabbit enterocyte basolateral-membrane vesicles. Biochem. J. 269:565-571 (1990).
14. K.-I. Inui, M. Yamamoto, and H. Saito. Transepithelial transport of oral cephalosporins by monolayers of intestinal epithelial cell line Caco-2: Specific transport system in apical and basolateral membrane. J. Pharmacol. Exp. Ther. 261:195-201 (1992).
15. H. Saito and K.-I. Inui. Dipeptide transporters in apical and basolateral membranes of the human intestinal cell line Caco-2. Am. J. Physiol. 265:G289-G294 (1993).
16. S.-I. Matumoto, H. Saito, and K.-I. Inui. Transepithelial transport of oral cephalosporins in human intestinal epithelial cells, Caco-2: Interaction with dipeptide transport systems in apical and basolateral membranes. J. Pharmcol. Exp. Ther. 270:498-504 (1994).
17. +-coupled carriers at both apical and basal membranes. J. Biol. Chem. 268:7640-7642 (1993).
18. I. J. Hidalgo, P. Bhatnagar, C.-P. Lee, J. Miller, G. Cucullino, and P. L. Smith. Structural requirments for interaction with the oligopeptide transporter in Caco-2 cells. Pharm. Res. 12:317-319 (1995).
19. I. J. Hidalgo, T. J. Raub, and R. T. Borchardt. Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability. Gastroenterology 96:736-749 (1989).
20. D. Wessel and U. I. Flugge. A method for the quantitative recovery of protein in dilute solution in the presence of detergents and lipids. Anal. Biochem. 138:141-143 (1984).
21. P. J. Chikhale and R. T. Borchardt. Metabolism of L-α-methyldopa in cultured human intestinal epithelial (Caco-2) cell monolayers. Comparison with metabolism in vivo. Drug Metab. Disp. 22:592-600 (1994).
22. D. M. Matthews, J. M. Addison, and D. Burston. Evidence for active transport of the dipeptide carnosine (βalanyl-L-histidine) by human jejunum in vitro. Clin. Sci. Molec. Med. 46:693-705 (1974).
23. J. M. Addison, D. M. Matthews, and D. Burston. Competition between carnosine and other peptides for transport by human jejunum in vitro. Clin. Sci. Molec. Med. 46:707-714 (1974).
24. M. L. G. Gardner. K. M. Illingworth, J. Kelleher, and D. Wood. Intestinal absorption of the intact peptide carnosine in man, and comparison with intestinal permeability to lactose. J. Physiol. 439:411-422 (1991).
25. K. M. Hillgren, P. F. Augustijns, and R. T. Borchardt. Carnosine as a substrate for the peptide carrier in Caco-2 cells. Pharm. Res. 10:S-181 (1993).